Back to results
US 2020/0206151 A1Published application
Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
AssigneeGW Pharma Limited
InventorsBRIAN ANTHONY WHITTLE, Farideh Afshin Javid
Life of this patent
Estimating the term…
Abstract
Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.
Claims16
1-15. (canceled)
A method of treating nausea, vomiting, or emesis in a mammal comprising administering a pharmaceutically acceptable amount of or an extract containing a pharmaceutically acceptable amount of CBD and/or CBDA and/or the propyl variants CBDV and/or CBDVA.
Dependencies are inferred from the claim text.